CLPT
Price:
$15.705
Market Cap:
$433.22M
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite. It has license and collaboration agreements with Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blac...[Read more]
Industry
Medical - Devices
IPO Date
2012-05-22
Stock Exchange
NASDAQ
Ticker
CLPT
According to ClearPoint Neuro, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 415.34M. This represents a change of 128.63% compared to the average of 181.66M of the last 4 quarters.
The mean historical Enterprise Value of ClearPoint Neuro, Inc. over the last ten years is 97.77M. The current 415.34M Enterprise Value has changed 42.38% with respect to the historical average. Over the past ten years (40 quarters), CLPT's Enterprise Value was at its highest in in the June 2021 quarter at 369.53M. The Enterprise Value was at its lowest in in the December 2016 quarter at 13.45M.
Average
97.77M
Median
53.76M
Minimum
10.54M
Maximum
255.99M
Discovering the peaks and valleys of ClearPoint Neuro, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 327.28%
Maximum Annual Enterprise Value = 255.99M
Minimum Annual Increase = -66.38%
Minimum Annual Enterprise Value = 10.54M
Year | Enterprise Value | Change |
---|---|---|
2023 | 157.87M | -16.56% |
2022 | 189.19M | -0.85% |
2021 | 190.81M | -25.46% |
2020 | 255.99M | 327.28% |
2019 | 59.91M | 241.63% |
2018 | 17.54M | 3.71% |
2017 | 16.91M | 60.39% |
2016 | 10.54M | -66.38% |
2015 | 31.35M | -34.15% |
2014 | 47.62M | -45.85% |
The current Enterprise Value of ClearPoint Neuro, Inc. (CLPT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
179.29M
5-year avg
170.76M
10-year avg
97.77M
ClearPoint Neuro, Inc.’s Enterprise Value is greater than Telesis Bio, Inc. (13.25M), greater than AVITA Medical, Inc. (262.23M), greater than Sight Sciences, Inc. (96.90M), less than Treace Medical Concepts, Inc. (492.22M), greater than NeuroPace, Inc. (390.59M), greater than Inogen, Inc. (115.25M), less than Surmodics, Inc. (560.63M), greater than Pulmonx Corporation (235.74M), greater than Apyx Medical Corporation (77.23M), greater than ProSomnus, Inc. (40.81M), less than LivaNova PLC (2.87B), greater than Electromed, Inc. (236.41M), less than OrthoPediatrics Corp. (520.22M), less than ShockWave Medical, Inc. (13.06B), less than Inari Medical, Inc. (3.13B), greater than Outset Medical, Inc. (228.17M), less than Inspire Medical Systems, Inc. (5.46B), greater than Cytosorbents Corporation (70.10M), greater than TELA Bio, Inc. (136.88M),
Company | Enterprise Value | Market cap |
---|---|---|
13.25M | $674.82K | |
262.23M | $338.47M | |
96.90M | $180.18M | |
492.22M | $434.21M | |
390.59M | $332.51M | |
115.25M | $200.79M | |
560.63M | $567.19M | |
235.74M | $243.25M | |
77.23M | $66.40M | |
40.81M | $8.18M | |
2.87B | $2.54B | |
236.41M | $250.27M | |
520.22M | $546.67M | |
13.06B | $12.57B | |
3.13B | $3.14B | |
228.17M | $59.37M | |
5.46B | $5.58B | |
70.10M | $48.97M | |
136.88M | $112.65M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ClearPoint Neuro, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ClearPoint Neuro, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is ClearPoint Neuro, Inc.'s Enterprise Value?
What is the highest Enterprise Value for ClearPoint Neuro, Inc. (CLPT)?
What is the 3-year average Enterprise Value for ClearPoint Neuro, Inc. (CLPT)?
What is the 5-year average Enterprise Value for ClearPoint Neuro, Inc. (CLPT)?
How does the current Enterprise Value for ClearPoint Neuro, Inc. (CLPT) compare to its historical average?